QUOTE AND NEWS
Forbes  Oct 24  Comment 
Looking back to 149 days ago, BioCryst Pharmaceuticals, Inc. (NASD: BCRX) priced a $100,000,000 secondary stock offering at $10.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment...
Benzinga  Oct 17  Comment 
Sarepta Therapeutics Inc (NASDAQ: SRPT) opened sharply higher Friday on news that its drug candidate for Ebola didn't present safety concerns in two small human trials. The company announced results of the studies on Thursday, which were...
Clusterstock  Oct 9  Comment 
Shares of Lakeland Industries were up more than 60% on Thursday. The company makes hazmat suits and its stock has been rallying following recent news of Ebola cases in Dallas and Spain. Thursday's rally brings Lakeland's recent rally nearly...
Benzinga  Oct 8  Comment 
The Texas Health Presbyterian Hospital issued a press release Wednesday announcing that the Ebola patient Eric Duncan has died. It appears this is the first case of an Ebola death in the United States. Shares of Ebola-related stocks have...
Benzinga  Oct 7  Comment 
CalAmp (NASDAQ: CAMP) shares jumped 8.24% to $17.86 in pre-market trading after the company reported better-than-expected Q2 earnings. BioCryst Pharmaceuticals (NASDAQ: BCRX) gained 6.11% to $12.50 in pre-market trading following the report of...
StreetInsider.com  Oct 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/BioCryst+Pharma+%28BCRX%29+Reports+BCX4161+Met+Primary+Endpoint+in+OPuS-1+Phase+2a/9891203.html for the full story.
Benzinga  Oct 6  Comment 
A market shake-out Monday of companies touting Ebola treatments left Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR) hurting while the fortunes of Chimerix Inc (NASDAQ: CMRX) flared. Chimerix obtained approval Monday of an emergency...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki